Apr 25, 2018  Novel scientific insights prompted a golden rush for RNA -- at least a dozen companies have programs dedicated to it, including big pharma (Biogen, Merck, Novartis, and Pfizer), and biotech startups like Arrakis Therapeutics with a $38M Series A round in 2017, and Expansion Therapeutics -- $55M Series A early in 2018. past #Ophelia in top Irish Twitter trends of 2017.
25 avril 2018  Novelle inspirazioni ştiinziali sulla una rispetta della RNA – a minimum una douzaine dei società ha programi dedicati a RNA, incluiendo il mare pharma (Biogen, Merck, Novartis e Pfizer), e i start-up biotech como Arrakis Therapeutics con una runde A del 2017 e Expansion Therapeutics – 55 mn april 2018.